share_log

和鉑醫藥-B：翌日披露報表

HBM HOLDINGS-B: Next Day Disclosure Return

香港交易所 ·  Apr 2 07:49
Summary by Moomoo AI
和鉑醫藥控股有限公司（和铂医药-B）於2024年4月2日根據香港聯合交易所有限公司證券上市規則披露其已發行股本變動。該公司通過股份獎勵計劃於同日發行了1,713,500股普通股，佔其發行前已發行股份的0.22%，每股發行價為0港元，相較於上一個營業日每股收市價1.38港元，折讓幅度為100%。此次發行後，公司的已發行股本增至770,142,410股。公司確認，所有相關的法律及規定程序已遵守，並且發行已獲董事會批准。
和鉑醫藥控股有限公司（和铂医药-B）於2024年4月2日根據香港聯合交易所有限公司證券上市規則披露其已發行股本變動。該公司通過股份獎勵計劃於同日發行了1,713,500股普通股，佔其發行前已發行股份的0.22%，每股發行價為0港元，相較於上一個營業日每股收市價1.38港元，折讓幅度為100%。此次發行後，公司的已發行股本增至770,142,410股。公司確認，所有相關的法律及規定程序已遵守，並且發行已獲董事會批准。
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) DISCLOSED THE CHANGES IN ITS ISSUED SHARE CAPITAL ON 2 APRIL 2024 IN ACCORDANCE WITH THE LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED. Through the Share Award Scheme, the Company issued 1,713,500 shares of ordinary shares on the same day, representing 0.22% of the shares issued prior to its issue, at an issue price of HK$0 per share, representing a discount of 100% compared to the market price of HK$1.38 per share on the previous business day. Following the issuance, the issued share capital of the company increased to 770,142,410 shares. The Company confirms that all relevant legal and regulatory procedures have been complied with and that the issuance has been approved by the Board of Directors.
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) DISCLOSED THE CHANGES IN ITS ISSUED SHARE CAPITAL ON 2 APRIL 2024 IN ACCORDANCE WITH THE LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED. Through the Share Award Scheme, the Company issued 1,713,500 shares of ordinary shares on the same day, representing 0.22% of the shares issued prior to its issue, at an issue price of HK$0 per share, representing a discount of 100% compared to the market price of HK$1.38 per share on the previous business day. Following the issuance, the issued share capital of the company increased to 770,142,410 shares. The Company confirms that all relevant legal and regulatory procedures have been complied with and that the issuance has been approved by the Board of Directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more